ARDS Berlin Criteria Calculator

About

The Berlin Definition of ARDS was developed by a European Society of Intensive Care Medicine (ESICM)-endorsed task force of 12 experts, convened in Berlin in October 2011. The definition was published in JAMA in 2012 by Ranieri et al. and has since become the global standard for ARDS diagnosis in clinical practice and research. The definition was motivated by several limitations of the 1994 AECC definition, including poor reliability of chest radiograph interpretation, lack of standardized PEEP requirements, ambiguous terminology regarding acute onset, and inadequate differentiation of severity subgroups. The Berlin task force used a consensus process combined with empirical evaluation of the definition against four large patient datasets comprising over 4,000 patients. The resulting definition requires four criteria for ARDS diagnosis: (1) onset within 1 week of a known clinical insult or new/worsening respiratory symptoms, (2) bilateral opacities on chest imaging (chest X-ray or CT) not fully explained by effusions, lobar/lung collapse, or nodules, (3) respiratory failure not fully explained by cardiac failure or fluid overload (an objective assessment such as echocardiography is recommended to exclude hydrostatic edema), and (4) moderate to severe hypoxemia defined by PaO₂/FiO₂ ≤ 300 mmHg with PEEP or CPAP ≥ 5 cmH₂O. Once diagnosed, ARDS is classified into three mutually exclusive severity categories based on PaO₂/FiO₂: Mild (201-300 mmHg), Moderate (101-200 mmHg), and Severe (≤100 mmHg). The Berlin definition has demonstrated improved predictive validity for mortality compared to the AECC definition, with mortality rates of 27%, 32%, and 45% for mild, moderate, and severe ARDS respectively, as reported in the original validation. The definition has been endorsed by the ESICM, ATS, and SCCM.

Formula

PaO₂/FiO₂ Ratio = PaO₂ (mmHg) / FiO₂ (decimal). Mild: 201-300, Moderate: 101-200, Severe: ≤100. All require PEEP/CPAP ≥5 cmH₂O + bilateral opacities + cardiac failure excluded + onset within 7 days.

The ARDS Berlin classification begins with confirming that all four diagnostic criteria are met before assigning a severity category. First, timing: respiratory symptoms or new deterioration must have developed within 7 days of a known clinical insult (pneumonia, aspiration, sepsis, pancreatitis, trauma, transfusion, inhalation injury, etc.) or new/worsening respiratory symptoms. Second, chest imaging: bilateral opacities must be present on chest X-ray or CT scan that are not fully explained by pleural effusions, atelectasis, lung collapse, or pulmonary nodules. Third, cardiac failure exclusion: respiratory failure must not be fully explained by cardiac failure or fluid overload. If no clear clinical risk factor for ARDS is present, objective assessment (e.g., echocardiography) is recommended to exclude hydrostatic pulmonary edema. Fourth, oxygenation: PaO₂/FiO₂ ratio ≤ 300 mmHg on PEEP or CPAP ≥ 5 cmH₂O. The PaO₂/FiO₂ ratio (also called P/F ratio or Horowitz index) is calculated by dividing the arterial partial pressure of oxygen (PaO₂ in mmHg) by the fraction of inspired oxygen (FiO₂ expressed as a decimal, e.g., 0.4 for 40% oxygen, 1.0 for 100% oxygen). For example, a patient with PaO₂ = 80 mmHg on FiO₂ = 0.5 has a P/F ratio of 80/0.5 = 160, which falls in the moderate ARDS category. The PEEP/CPAP requirement of ≥5 cmH₂O ensures that hypoxemia is not simply due to low lung volume or atelectasis without positive pressure. For mild ARDS, CPAP ≥5 cmH₂O via non-invasive ventilation is acceptable. For moderate and severe ARDS, intubation and mechanical ventilation with PEEP ≥5 cmH₂O are typical. The severity classification predicts mortality: mild 27%, moderate 32%, severe 45% (from the original Berlin validation cohort). Importantly, severity should be reassessed over time as the patient's condition changes — improvement or worsening may shift categories.

Score Interpretation

The Berlin Definition of ARDS is the globally accepted standard for ARDS diagnosis and classification, endorsed by the ESICM, ATS, and SCCM. It is used in virtually all major ARDS clinical trials and observational studies, including landmark trials on low tidal volume ventilation (ARMA trial), prone positioning (PROSEVA trial), neuromuscular blockade (ACURASYS trial), and ECMO (CESAR and EOLIA trials). The definition has been adopted by the Surviving Sepsis Campaign (SSC) guidelines for sepsis-associated ARDS management. The Berlin definition significantly improved upon the AECC definition in several ways: (1) it eliminated the term "acute lung injury (ALI)" which was confusing and encompassed mild ARDS under the new classification, (2) it standardized PEEP requirements to ≥5 cmH₂O, (3) it required objective exclusion of cardiac failure, (4) it provided explicit criteria for chest imaging interpretation, and (5) it demonstrated improved predictive validity with clear mortality gradients across severity categories. In clinical practice, the Berlin criteria guide: (1) diagnosis verification before enrollment in ARDS-specific protocols, (2) severity-based ventilation strategy selection (PEEP titration, prone positioning, neuromuscular blockade), (3) prognostication and family communication, (4) eligibility for advanced therapies (ECMO for severe ARDS with refractory hypoxemia), and (5) enrollment in clinical trials. The definition has limitations: it does not account for the etiological subtype (pulmonary vs. extrapulmonary ARDS), it requires arterial blood gas sampling, and the P/F ratio is influenced by ventilator settings, particularly PEEP and FiO₂. The "Berlin 2.0" or "Global Definition of ARDS" is currently under development with anticipated updates including feasibility in resource-limited settings, alternative oxygenation metrics (SpO₂/FiO₂), and ultrasound-based lung assessment.

Reference Ranges